Abiopharma

Clinical trial NCT07722585 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. primary completion date: 2026-11-04 → 2026-10-28

Clinical trial NCT07306364: start date: 2026-06-01 → 2026-10-01.

Clinical trial NCT07725237 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-06-01 → 2026-07-20

Clinical trial NCT07444567 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-05-25 → 2026-07-24 3. completion date: 2029-12-28 → 2030-01-03 4. primary completion date: 2029-12-28 → 2030-01-03 5. allocation: NA → NON_RANDOMIZED

Clinical trial NCT05977140: enrollment: 116 → 94 participants.

Clinical trial NCT07662798: status: RECRUITING → ACTIVE_NOT_RECRUITING.

Clinical trial NCT07625280 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-06-30 → 2026-07-09 3. enrollment: 108 → 120 participants

Clinical trial NCT05196035 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2027-06-30 → 2027-05-10 3. primary completion date: 2027-05-31 → 2027-04-10

Clinical trial NCT07480564 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: 3 → 4 participants 3. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT05361720 updates: 1. completion date: 2027-07-01 → 2028-07-01 2. primary completion date: 2026-10-01 → 2027-10-01

Clinical trial NCT04893109 updates: 1. completion date: 2028-05-01 → 2029-05-01 2. primary completion date: 2026-11-01 → 2028-11-01

Clinical trial NCT07556757 updates: 1. status: RECRUITING → TERMINATED 2. completion date: 2028-12-01 → 2026-07-01 3. primary completion date: 2028-12-01 → 2026-07-01 4. enrollment: 10 → 4 participants 5. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT01559935 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2027-03-01 → 2026-03-19

Clinical trial NCT07485582: start date: 2026-04-01 → 2026-09-01.

Clinical trial NCT04999969: completion date: 2026-06-30 → 2026-11-30.